Table3 In-Hospital outcome.
Major adverse events | Overall | Group I (< 24 h) (%) | Group II (24–48 h) (%) | Group III (48–72 h) (%) | Group IV (> 72 h) (%) | P-value |
|---|---|---|---|---|---|---|
Total | 2835 | 814 | 526 | 403 | 1092 | |
Death | 5(0.2) | 2(0.2) | 1(0.2) | 1(0.2) | 1(0.1) | 0.851 |
Cardiac death | 5(100) | 2(100) | 1(100) | 1(100) | 1(100) | 0.881 |
Congestive heart failure | 128(4.5) | 27(3.3) | 19(3.6) | 20(5) | 62(5.7) | 0.062 |
Cardiogenic shock (killip IV) | 24(0.8) | 9(1.1) | 7(1.3) | 4(1) | 4(0.4) | 0.156 |
Stroke | 10(0.4) | 3(0.4) | 0(0) | 0(0) | 7(0.6) | 0.118 |
Hemorrhagic stroke | 8(80) | 3(100) | 0(0) | 0(0) | 5(71.4) | 0.187 |
Major bleeding | 43(1.5) | 11(1.4) | 7(1.3) | 4(1) | 18(1.6) | 0.913 |
